Tag: CORO
Adenovirus Type-5 Vectored COVID-19 Vaccine Shows Promise
ELISA antibodies and neutralizing antibodies increased at day 14, peaked at day 28
Hydroxychloroquine Plus Macrolides No Benefit in COVID-19
Hydroxychloroquine, chloroquine with or without macrolides linked to in-hospital mortality, arrhythmia
Remdesivir Beats Placebo for Time to COVID-19 Recovery
Researchers suggest antiviral agents in combination with other therapeutic approaches may further improve outcomes
WHO Suspends Testing of Hydroxychloroquine in COVID-19 Patients
In light of recent findings, hydroxychloroquine arm of WHO global study paused temporarily
ED Chest X-Ray Score Predicts COVID-19 Outcomes in Adults <50
CXR severity score ≥2 and obesity independent predictors of hospital admission
Cardiac Decompensation Seen in Children Following COVID-19
Cardiac decompensation occurred in conjunction with multisystem inflammatory syndrome in some children
Incidence of AMI Hospitalization Down During COVID-19
Decrease seen in incidence of STEMI, NSTEMI in Northern California during COVID-19 period versus pre-COVID-19
No SARS-CoV-2 ID’d in Asymptomatic Pregnant Women in Los Angeles
Among 80 asymptomatic pregnant women admitted to Cedars-Sinai Medical Center, none tested positive
Delays in Cancer Surgery Due to COVID-19 Could Harm Survival
Per-patient delay of three or six months would result in an estimated 92,214 or 208,275 life-years lost
U.S. Offers $1.2 Billion to Drug Company for COVID-19 Vaccine Research
Deal will fund phase 3 clinical trial in the United States this summer with about 30,000 volunteers
